老虎證券
Invest
Pricing
Rewards
Support
About
Quotes
TigerAI
登入
立即註冊
Toggle
澳股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
Renerve Ltd
0.071
0.000
成交量:
3.24萬
成交額:
2,303
市值:
1,230.26萬
市盈率:
-2.03
高:
0.072
開:
0.072
低:
0.071
收:
0.071
52周最高:
0.220
52周最低:
0.068
股本:
1.73億
流通股本:
6,522.49萬
量比:
0.42
換手率:
0.05%
股息:
- -
股息率:
- -
每股收益(TTM):
-0.035
每股收益(LYR):
-0.035
淨資產收益率:
-133.13%
總資產收益率:
-75.92%
市淨率:
3.87
市盈率(LYR):
-2.03
資料載入中...
總覽
公司
新聞資訊
公告
ReNerve旗下Nervalign神經套囊獲印度CDSCO上市許可
投资观察
·
08/10
Renerve宣佈新分銷協議,拓展香港市場覆蓋範圍
投资观察
·
06/01
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/hant/stock/RNV.AU/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"RNV.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"RNV.AU\",,,,,undefined,":{"symbol":"RNV.AU","market":"AU","secType":"STK","nameCN":"Renerve Ltd","latestPrice":0.071,"timestamp":1789625520000,"preClose":0.071,"halted":0,"volume":32421,"delay":0,"changeRate":0,"nameEN":"Renerve Ltd","floatShares":65224917,"shares":173276436,"eps":-0.035036,"marketStatus":"未開盤","change":0,"latestTime":"09-17 16:12:00 AEST","open":0.072,"high":0.072,"low":0.071,"amount":2303,"amplitude":0.014085,"askPrice":0.077,"askSize":2036,"bidPrice":0.071,"bidSize":150000,"shortable":3,"etf":0,"ttmEps":-0.035036,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":0,"beginTime":1789689600000},"marketStatusCode":0,"adr":0,"listingDate":1732194000000,"exchange":"ASX","adjPreClose":0.071,"openAndCloseTimeList":[[1789603200000,1789624800000]],"volumeRatio":0.41945475216881395,"lotSize":0,"tradeCurrency":"AUD","auctionPricing":{"symbol":"RNV.AU","preClose":0.074,"auctionPrice":0.07,"auctionVolume":1647,"auction":3,"marketStatus":"盘后竞价","timestamp":1789366200512}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"RNV.AU\",,,,,undefined,":{"symbol":"RNV.AU","floatShares":65224917,"roa":"-75.92%","roe":"-133.13%","lyrEps":-0.035,"volumeRatio":0.41945475216881395,"shares":173276436,"dividePrice":0,"high":0.072,"amplitude":0.014085,"preClose":0.071,"low":0.071,"week52Low":0.068,"pbRate":"3.87","psRate":"24.11","week52High":0.22,"institutionHeld":0,"latestPrice":0.071,"committee":0.973217,"eps":-0.035036,"divideRate":0,"volume":32421,"delay":0,"ttmEps":-0.035036,"open":0.072,"prevYearClose":0.1,"prevWeekClose":0.074,"prevMonthClose":0.077,"prevQuarterClose":0.077,"fiveDayClose":0.068,"twentyDayClose":0.08,"sixtyDayClose":0.081},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RNV.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RNV.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RNV.AU\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1144808177","title":"ReNerve旗下Nervalign神經套囊獲印度CDSCO上市許可","url":"https://stock-news.laohu8.com/highlight/detail?id=1144808177","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1144808177?lang=zh_tw&edition=fundamental","pubTime":"2026-08-10 09:56","pubTimestamp":1786326999,"startTime":"0","endTime":"0","summary":"8月10日,ReNerve Ltd宣布,其Nervalign神经套囊产品已获得印度药品管理总局(CDSCO)的上市批准。此举标志着该公司在印度市场的拓展迈出关键一步。相关代码为RNV.AX。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNV.AU","BK7126"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161412999","title":"Renerve宣佈新分銷協議,拓展香港市場覆蓋範圍","url":"https://stock-news.laohu8.com/highlight/detail?id=1161412999","media":"投资观察","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161412999?lang=zh_tw&edition=fundamental","pubTime":"2026-06-01 09:51","pubTimestamp":1780278695,"startTime":"0","endTime":"0","summary":"Renerve有限公司宣布,已与一家瑞典贸易公司签署了新的分销协议,旨在将其业务覆盖范围扩展至更广泛的香港市场。\n根据协议条款,此次合作将覆盖香港、澳门以及整个粤港澳大湾区,该区域总人口约为8800万。协议在初始的三年期限内为独家性质,并包含后续的续约选项。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNV.AU","BK7126"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":2,"code":"91000000","status":"200"}]}}